Bicocca Open Archive

Logo unimib boa
LOCATELLI, VITTORIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 14.085
AS - Asia 7.358
EU - Europa 5.889
SA - Sud America 958
AF - Africa 156
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 14
Totale 28.478
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 13.463
SG - Singapore 2.283
CN - Cina 1.605
IT - Italia 1.474
VN - Vietnam 1.435
HK - Hong Kong 904
DE - Germania 828
RU - Federazione Russa 805
BR - Brasile 714
CA - Canada 535
SE - Svezia 531
IE - Irlanda 519
UA - Ucraina 501
GB - Regno Unito 350
IN - India 238
FR - Francia 223
FI - Finlandia 174
BD - Bangladesh 135
AT - Austria 121
KR - Corea 118
ID - Indonesia 97
TR - Turchia 96
AR - Argentina 84
IQ - Iraq 82
NL - Olanda 63
DK - Danimarca 54
PL - Polonia 52
ZA - Sudafrica 51
MX - Messico 48
CO - Colombia 47
PK - Pakistan 46
SA - Arabia Saudita 45
BE - Belgio 44
EC - Ecuador 41
JP - Giappone 40
ES - Italia 35
PH - Filippine 34
CH - Svizzera 30
MY - Malesia 27
UZ - Uzbekistan 25
BG - Bulgaria 22
CL - Cile 18
NP - Nepal 18
KE - Kenya 17
MA - Marocco 17
TN - Tunisia 17
VE - Venezuela 16
AU - Australia 15
LB - Libano 13
PY - Paraguay 13
TW - Taiwan 13
EG - Egitto 12
PE - Perù 12
EU - Europa 11
OM - Oman 11
CZ - Repubblica Ceca 10
AL - Albania 9
AZ - Azerbaigian 9
IL - Israele 9
IR - Iran 9
JM - Giamaica 9
KZ - Kazakistan 9
PS - Palestinian Territory 9
UY - Uruguay 9
AE - Emirati Arabi Uniti 8
ET - Etiopia 8
JO - Giordania 8
TH - Thailandia 8
CR - Costa Rica 7
EE - Estonia 7
HN - Honduras 7
KG - Kirghizistan 7
RO - Romania 7
DZ - Algeria 5
GT - Guatemala 5
PT - Portogallo 5
AO - Angola 4
BO - Bolivia 4
HR - Croazia 4
LT - Lituania 4
RS - Serbia 4
SC - Seychelles 4
BY - Bielorussia 3
HU - Ungheria 3
MN - Mongolia 3
NG - Nigeria 3
NZ - Nuova Zelanda 3
QA - Qatar 3
SN - Senegal 3
BH - Bahrain 2
CD - Congo 2
DO - Repubblica Dominicana 2
GA - Gabon 2
GR - Grecia 2
KW - Kuwait 2
LA - Repubblica Popolare Democratica del Laos 2
MD - Moldavia 2
ML - Mali 2
MR - Mauritania 2
MU - Mauritius 2
Totale 28.453
Salva come PNG Salva come JPEG
Città #
Ann Arbor 1.605
Singapore 1.315
Ashburn 1.224
Woodbridge 1.090
Fairfield 979
Hong Kong 893
Houston 797
Chandler 736
Wilmington 721
San Jose 674
Frankfurt am Main 562
Jacksonville 506
Dublin 496
Seattle 447
Ho Chi Minh City 438
Milan 438
Hanoi 349
Dearborn 323
Toronto 322
Cambridge 310
Beijing 309
New York 282
Chicago 216
Princeton 211
Santa Clara 205
Los Angeles 187
Hefei 179
Dallas 151
The Dalles 141
Nanjing 136
Seoul 108
Vienna 106
Lauterbourg 100
Council Bluffs 97
Rome 88
Lawrence 87
Altamura 86
Shanghai 83
Boardman 82
Lachine 82
Moscow 79
Buffalo 75
Jakarta 74
São Paulo 67
Helsinki 65
Da Nang 63
Guangzhou 53
Haiphong 53
London 52
Detroit 49
Brussels 41
Nanchang 41
San Diego 41
Falls Church 40
Baghdad 37
Munich 36
Hebei 32
Orem 32
Andover 29
Nuremberg 29
Tokyo 29
Warsaw 29
Biên Hòa 27
Changsha 27
Kent 27
Shenyang 27
Mountain View 26
Rio de Janeiro 26
Tianjin 26
Pune 25
Ha Long 24
Huizen 24
San Francisco 24
Elora 23
Fremont 23
Atlanta 22
Bologna 22
Denver 22
Tashkent 22
Philadelphia 21
Salt Lake City 21
Brooklyn 20
Grafing 20
Hải Dương 20
Jiaxing 20
Can Tho 19
Dhaka 19
Jinan 19
Ottawa 19
Renton 19
Turin 19
Turku 19
Poplar 18
Riyadh 18
Stockholm 18
Hangzhou 17
Kunming 17
Monza 17
Phoenix 17
Quận Bình Thạnh 17
Totale 19.018
Salva come PNG Salva come JPEG
Nome #
Selected Growth Hormone Secretagogues (GHS) as disease modifiers in an in vitro model of Amyotrophic Lateral Sclerosis: a proof-of-concept study 501
Anti-inflammatory effects of palmitoylethanolamide in activated microglial cells 459
Selected Growth Hormone Secretagogues (GHS) decrease mutant SOD1 toxicity in an in vitro model of amyotrophic lateral sclerosis 448
Growth hormone secretagogues and the regulation of calcium signaling in muscle 447
Intra-Articular Cytokine Levels in Adolescent Patients after Anterior Cruciate Ligament Tear 397
Biophysical characterization of a binding site for TLQP-21, a naturally occurring peptide which induces resistance to obesity 394
TLQP-21, A VGF-derived peptide endowed of endocrine and extraendocrine properties: Focus on in vitro calcium signaling 394
Effects of ACL Reconstructive Surgery on Temporal Variations of Cytokine Levels in Synovial Fluid 376
Neurotrophic and neuroregenerative effects of GH/IGF1 359
Hexarelin modulation of mapk and pi3k/akt pathways in neuro-2a cells inhibits hydrogen peroxide-induced apoptotic toxicity 355
Role of interleukin-10 in the synovial fluid of the anterior cruciate ligament injured knee 348
Novel domain-selective ACE-inhibiting activity of synthetic growth hormone secretagogues 343
STIM Proteins and Orai Ca2+ Channels Are Involved in the Intracellular Pathways Activated by TLQP-21 in RAW264.7 Macrophages 339
Development of Growth Hormone Secretagogues as new therapeutical tools for Amyotrophic Lateral Sclerosis 331
Potential Applications for Growth Hormone Secretagogues Treatment of Amyotrophic Lateral Sclerosis 320
Feeding behavior during long-term hexarelin administration in young and old rats 306
Characterization of synovial fluid cytokine profiles in chronic meniscal tear of the knee 306
miRNA Expression Profiling in Subcutaneous Adipose Tissue of Monozygotic Twins Discordant for HIV Infection: Validation of Differentially Expressed miRNA and Bioinformatic Analysis 306
Protective Effects of Hexarelin and JMV2894 in a Human Neuroblastoma Cell Line Expressing the SOD1-G93A Mutated Protein 305
JMV2894, a novel growth hormone secretagogue, accelerates body mass recovery in an experimental model of cachexia 303
Acute and late changes in intraarticular cytokine levels following anterior cruciate ligament injury 298
Hexarelin modulates lung mechanics, inflammation, and fibrosis in acute lung injury 297
Ontogeny and tissue-specific regulation of ghrelin mRNA expression suggest that ghrelin is primarily involved in the control of extraendocrine functions in the rat 294
Ghrelin in gastroenteric pathophysiology 291
Ghrelin plays a minor role in the physiological control of cardiac function in the rat 288
Pharmacological and Biochemical Characterization of TLQP-21 Activation of a Binding Site on CHO Cells 288
Ghrelin control of GH secretion and feeding behaviour: The role of the GHS-R1a receptor studied in vivo and in vitro using novel non-peptide ligands 284
Chronic intracerebroventricular injection of TLQP-21 prevents high fat diet induced weight gain in fast weight-gaining mice 283
JMV5656, a novel derivative of TLQP-21, triggers the activation of a calcium-dependent potassium outward current in microglial cells 282
Hexarelin modulates the expression of growth hormone secretagogue receptor type 1a mRNA at hypothalamic and pituitary sites 281
TLQP-21, a VGF-derived peptide, increases energy expenditure and prevents the early phase of diet-induced obesity 280
Desacyl-ghrelin and Synthetic GH-secretagogues Modulate the Production of Inflammatory Cytokines in Mouse Microglia Cells Stimulated by beta-Amyloid Fibrils 279
Central ghrelin gastroprotection involves nitric oxide/prostaglandin cross-talk 276
Central dysregulations in the control of energy homeostasis and endocrine alterations in anorexia and bulimia nervosa 274
Central nervous system-acting drugs influencing hypothalamic-pituitary-adrenal axis function 274
Characterization of microRNA Levels in Synovial Fluid from Knee Osteoarthritis and Anterior Cruciate Ligament Tears 272
Characterization of a novel peripheral pro-lipolytic mechanism in mice: role of VGF-derived peptide TLQP-21 272
Ghrelin expression and actions: A novel peptide for an old cell type of the diffuse endocrine system 269
Obestatin inhibits feeding but does not modulate GH and corticosterone secretion in the rat 267
Characterisation of gastric ghrelin cells in man and other mammals: studies in adult and fetal tissues 263
Utilizzo dei growth hormone secretagogues per bloccare o inibire l'attività del sistema renina-angiotensina 257
miRNA-218 targets lipin-1 and glucose transporter type 4 genes in 3T3-L1 cells treated with lopinavir/ritonavir 255
Intracerebroventricular acute and chronic administration of obestatin minimally affect food intake but not weight gain in the rat. 254
New trisubstituted 1,2,4-triazole derivatives as potent ghrelin receptor antagonists. 3. Synthesis and pharmacological in vitro and in vivo evaluations 254
Selected Growth Hormone Secretagogues (GHS) as promising therapeutical approach for Amyotrophic Lateral Sclerosis: a proof-of-concept study 251
Involvement of the somatostatin and cholinergic systems in the mechanism of growth hormone autofeedback regulation in the rat 250
Beneficial effects of desacyl-ghrelin, hexarelin and EP-80317 in models of status epilepticus 249
Effects of hexarelin against acid-independent and acid-dependent ulcerogens in the rat 248
Mechanism of action of Hexarelin. I. Growth hormone-releasing activity in the rat 248
Penile erection induced by EP 80661 and other hexarelin peptide analogues: Involvement of paraventricular nitric oxide 247
Age-dependent modulation by galanin of growth hormone release from rat pituitary cells in culture 247
Somatotropic dysregulation in old mammals 246
La valutazione delle attività di tirocinio pratico da parte dei tutori 246
Studio longitudinale sul benessere e le attitudini degli Studenti di Medicina e Chirurgia. Primi risultati della fase 1 - Le caratteristiche degli studenti selezionati. 245
Inibition of H2O2-induced neurotoxicity in mouse neuroblastoma Neuro2A cells by microvescicles released from hexarelin-stimulated microglial cells 244
Evidence for a central inhibitory role of growth hormone secretagogues and ghrelin on gastric acid secretion in conscious rats 243
Changes in subcutaneous adipose tissue microRNA expression in HIV-infected patients 239
Growth hormone-inhibiting activity of cortistatin in the rat 233
Ghrelin inhibits inflammatory pain in rats: Involvement of the opioid system 232
Novel hexarelin analogs stimulate feeding in the rat through a mechanism not involving growth hormone release 232
Growth hormone-releasing hexapeptide is a potent stimulator of growth hormone gene expression and release in the growth hormone-releasing hormone-deprived infant rat 231
Functional and Structural Characterization of a Binding Site for TLQP-21, a VGF-Derived Peptide 228
EP 60761 and EP 50885, two hexarelin analogues, induce penile erection in rats 228
IGF-I stimulates proliferation of spontaneously immortalized human keratinocytes (HACAT) by autocrine/paracrine mechanisms 226
GH-releasing activity of Hexarelin, a new growth hormone releasing peptide, in infant and adult rats 224
Moexipril and quinapril inhibition of tissue angiotensin-converting enzyme activity in the rat: Evidence for direct effects in heart, lung and kidney and stimulation of prostacyclin generation 223
Hexarelin stimulation of growth hormone release and mrna levels in an infant and adult rat model of impaired ghrh function 221
Low dose of insulin for assessment of growth hormone and cortisol release in short children 220
Short ghrelin peptides neither displace ghrelin binding in vitro nor stimulate GH release in vivo 220
Growth hormone and hexarelin prevent endothelial vasodilator dysfunction in aortic rings of the hypophysectomized rat 220
Ghrelin expression in gut endocrine growths 219
The somatostatin subtype-2 receptor antagonist, BIM-23627, improves the catabolic effects induced by long-term glucocorticoid treatment in the rat. 218
Long-term changes of somatotrophic function induced by deprivation of growth hormone-releasing hormone during the fetal life of the rat 218
Effects of GH and IGF-I administration on GHRH and somatostatin mRNA levels: I. A study on ad libitum fed and starved adult male rats 218
Cholinergic agonist and antagonist drugs modulate the growth hormone response to growth hormone-releasing hormone in the rat: evidence for mediation by somatostatin 217
Toward potent ghrelin receptor ligands based on trisubstituted 1,2,4-triazole structure. 2. Synthesis and pharmacological in vitro and in vivo evaluations 216
Effect of GH/IGF-1 on Bone Metabolism and Osteoporsosis 215
Protective but not anticonvulsant effects of ghrelin and JMV-1843 in the pilocarpine model of Status epilepticus 214
Neural stem cells release soluble factors that modulate inflammatory cytokines expression in microglia 213
Pyruvate and satiety: can we fool the brain? 210
Growth hormone secretagogues: focus on the growth hormone-releasing peptides 210
Key Learning Outcomes for Clinical Pharmacology and Therapeutics Education in Europe: A Modified Delphi Study 209
La somatopausa: nuove prospettive terapeutiche 208
Somatotropic dysfunction in growth hormone-releasing hormone-deprived neonatal rats: effect of growth hormone replacement therapy 207
Involvement of brain catecholamines and acetylcholine in growth hormone hypersecretory states. Pathophysiological, diagnostic and therapeutic implications 203
Growth hormone-independent cardioprotective effects of hexarelin in the rat 203
PHARMACOLOGICAL CHARACTERIZATION OF A BINDING SITE FOR TLQP-21, A VGF-DERIVED PEPTIDE 203
Effects of GH and IGF-I administration on GHRH and somatostatin mRNA levels: II. A study in the infant rat 201
Chronic intracerebroventricular TLQP-21 delivery does not modulate the GH/IGF-1-axis and muscle strength in mice 200
Potential application of Growth Hormone Secretagogues (GHS) for Amyotrophic Lateral Sclerosis (ALS) treatment: mechanisms of action and neuroprotective effects characterization in human SH-SY5Y SOD1G93A cells 199
Ghrelin protects against ethanol-induced gastric ulcers in rats: studies on the mechanisms of action 196
Testosterone a key factor in gender related metabolic syndrome 196
Potential Applications for Growth Hormone Secretagogues Treatment of Amyotrophic Lateral Sclerosis: the case of hexarelin and JMV2894 193
Antioxidant and neuroprotective effects of Hexarelin in Neuro-2A cells 193
Age-related modulatory activity by a cholinergic agonist on the growth hormone response to GH-releasing hormone in the rat 192
New active series of growth hormone secretagogues 191
EP 60761- and EP 50885-induced penile erection: structure-activity studies and comparison with apomorphine, oxytocin and N-methyl-D-aspartic acid 190
Synthesis and pharmacological in vitro and in vivo evaluations of novel triazole derivatives as ligands of the ghrelin receptor. 1 188
L’accesso a Medicina. Best evidence-based practice, requisito indispensabile per una ipotesi di “Processo di Selezione” centrato sulla realtà formativa italiana e di caratura internazionale 185
Chronic i.c.v infusion either of a melanocortin agonist or of an antagonist at low doses profoundly modifies energy balance without any other behavioral effects, in rats 184
Totale 26.219
Salva come PNG Salva come JPEG
Categoria #
all - tutte 90.991
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 90.991
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.199 63 109 149 57 52 113 57 51 83 109 118 238
2022/20232.766 284 742 282 282 239 421 30 143 181 17 90 55
2023/20241.584 63 73 78 83 225 395 313 44 105 18 28 159
2024/20253.743 215 352 234 239 349 161 271 223 257 519 281 642
2025/202610.129 1.467 815 695 968 984 506 1.350 464 875 775 619 611
Totale 28.911